146 related articles for article (PubMed ID: 18592070)
1. HPV vaccine catch up schedule - an opportunity for chlamydia screening.
Grotowski M; May J
Aust Fam Physician; 2008 Jul; 37(7):529-30. PubMed ID: 18592070
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
3. HPV vaccination catch up program - utilisation by young Australian women.
Weisberg E; Bateson D; McCaffery K; Skinner SR
Aust Fam Physician; 2009; 38(1-2):72-6. PubMed ID: 19283241
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
5. Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time.
Bosch FX
J Natl Cancer Inst; 2009 Jun; 101(11):771-3. PubMed ID: 19470950
[No Abstract] [Full Text] [Related]
6. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
7. [Human papillomavirus vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].
Abarca V K; Valenzuela B MT; Vergara F R; Luchsinger F V; Muñoz M A; Jiménez de la Jara J; Ripoll M E; O'Ryan G M
Rev Chilena Infectol; 2008 Dec; 25(6):428-34. PubMed ID: 19194605
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer: the second-generation vaccines move forward.
Tuma RS
J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
[No Abstract] [Full Text] [Related]
9. [HPV and effectiveness of chlamydia control].
Lehtinen M; Eriksson T; Apter D
Duodecim; 2009; 125(13):1377-84. PubMed ID: 19678493
[TBL] [Abstract][Full Text] [Related]
10. Primary and secondary prevention of cervical cancer--opportunities and challenges.
Markowitz LE; Unger ER; Saraiya M
J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
[No Abstract] [Full Text] [Related]
11. Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine.
Barthell E; Woelber L; Hellner K; Camerer B; Gieseking F; Hauschild M; Mylonas I; Friese K; Sings HL; Railkar R; Gause C; Barr E
Arch Gynecol Obstet; 2009 Jun; 279(6):803-7. PubMed ID: 18936950
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain.
Gauthier A; Martín-Escudero V; Moore L; Ferko N; de Sanjosé S; Pérez-Escolano I; Catalá-López F; Ferrer E; Bosch FX
Eur J Public Health; 2008 Dec; 18(6):674-80. PubMed ID: 18641420
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.
Jain N; Euler GL; Shefer A; Lu P; Yankey D; Markowitz L
Prev Med; 2009 May; 48(5):426-31. PubMed ID: 19100762
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
15. [HPV vaccine and cervical cancer prevention in general practice. Survey conducted among general practitioners in the French departments of Eure-et-Loir and Cher].
Pélissier G; Bastides F
Rev Prat; 2008 Dec; 58(19 Suppl):25-31. PubMed ID: 19253788
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
17. The case for vaccinating boys against human papillomavirus.
Hull SC; Caplan AL
Public Health Genomics; 2009; 12(5-6):362-7. PubMed ID: 19684448
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccine: a paradigm shift for pediatricians.
Jenson HB
Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.
Herrero R
J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
